{"count":6,"index":{"built_at":"2026-07-27T14:11:31.789530+00:00","public_records":55311,"revision":"274d76f140af88732c36833b"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: LDL in the context of Wechseljahre"},"results":[{"answer":"The link between LDL cholesterol and menopause is well-established: declining estrogen levels typically raise LDL, increasing cardiovascular risk. Evidence is human-strong (epidemiological and physiological studies). However, consumer DNA tests (e.g., MyBody-X) cannot reliably predict this rise – they provide only weak polygenic hints. A blood lipid panel is far more informative for individual risk assessment. Caveat: Menopause is a natural transition, but elevated LDL should be monitored by a physician, especially with other risk factors. Evidence for nutrigenetic tests in this context is marketing-based and not clinically validated.","area":"gesundheit","canonical_id":"gesundheit:canonical-da46c57024aabef57a6c1318","id":"public-bfaee874fdb877726ac70b1e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: LDL in the context of Wechseljahre","score":22.46999306,"snippet":"The link between LDL cholesterol and menopause is well-established: declining estrogen levels typically raise LDL, increasing cardiovascular risk. Evidence is human-strong (epidemiological and physiological studies). However, consumer DNA tests (e.g., MyBody-X) cannot reliably predict this rise – they provide only weak polygenic hints. A blood lipid panel is far more informative for individual risk assessment. Caveat: Menopause is a natural transition, but elevated LDL should be monitored by a physician, especially with other risk factors. Evidence for nutrigenetic tests in this context is marketing-based and not clinically validated.","sources":[],"title":"Evidence check: LDL in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-bfaee874fdb877726ac70b1e/evidence-check-ldl-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL) in the blood and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. During menopause, estrogen decline leads to increased LDL and ApoB levels, along with a shift toward smaller, denser LDL particles – a particularly atherogenic profile. The evidence for ApoB as a risk marker in menopause is solid (prospective cohorts, meta-analyses). However, randomized trials specifically targeting ApoB in postmenopausal women are lacking. Current guidelines (ESC, AHA) recommend ApoB as an alternative or complementary marker, especially in women with metabolic syndrome or diabetes. An ApoB target < 80 mg/dL (or < 65 mg/dL for high risk) is often suggested. MyBody-X tests can measure ApoB, but interpretation requires clinical context. Caveat: No home test replaces a physician's risk assessment. Evidence: human-moderate (strong association, but no RCTs for menopause-specific cutoffs).","area":"gesundheit","canonical_id":"gesundheit:canonical-7dfcad29b2db1f026e1efda9","id":"public-03f01f467a517f852cc05e3f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of Wechseljahre","score":21.94823624,"snippet":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL) in the blood and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. During menopause, estrogen decline leads to increased LDL and ApoB levels, along with a shift toward smaller, denser LDL particles – a particularly atherogenic profile. The evidence for ApoB as a risk marker in menopause is solid (prospective cohorts, meta-analyses). However, randomized trials specifically targeting ApoB in postmenopausal women are lacking. Current guidelines (ESC, AHA) recommend ApoB as an alternative or complementary marker, especially in women with metabolic syndrome or diabete","sources":[],"title":"Evidence check: ApoB in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-03f01f467a517f852cc05e3f/evidence-check-apob-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Menopause (Wechseljahre) involves hormonal shifts that can alter lipid profiles. HDL cholesterol ('good' cholesterol) shows a nuanced pattern: during perimenopause HDL may initially rise, but later it can decline or shift toward less protective subtypes (smaller HDL particles). Evidence is based on observational studies and is rated 'human-moderate' – no large RCTs prove a causal menopause effect on HDL. Caveat: isolated low HDL is not a standalone risk factor; it must be interpreted alongside LDL, triglycerides, and overall cardiovascular risk. Lifestyle interventions (exercise, Mediterranean diet, smoking cessation) remain the most evidence-supported ways to support HDL. Hormone therapy may raise HDL but its clinical benefit is debated. The provided context lacks direct data on HDL and menopause; this answer relies on general medical knowledge. Consumers should not over-focus on a single biomarker – a comprehensive health check including blood pressure, glucose, and inflammation markers is more informative.","area":"gesundheit","canonical_id":"gesundheit:canonical-8a1d96215378bf1d195e0af8","id":"public-3fd14b1cbabd6d5fe86f0d7b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: HDL in the context of Wechseljahre","score":20.74835065,"snippet":"Menopause (Wechseljahre) involves hormonal shifts that can alter lipid profiles. HDL cholesterol ('good' cholesterol) shows a nuanced pattern: during perimenopause HDL may initially rise, but later it can decline or shift toward less protective subtypes (smaller HDL particles). Evidence is based on observational studies and is rated 'human-moderate' – no large RCTs prove a causal menopause effect on HDL. Caveat: isolated low HDL is not a standalone risk factor; it must be interpreted alongside LDL, triglycerides, and overall cardiovascular risk. Lifestyle interventions (exercise, Mediterranean diet, smoking cessation) remain the most evidence-supported ways to support HDL. Hormone therapy ma","sources":[],"title":"Evidence check: HDL in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3fd14b1cbabd6d5fe86f0d7b/evidence-check-hdl-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":20.7089221,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","area":"gesundheit","canonical_id":"gesundheit:canonical-b9f3befe093edff5f40c1753","id":"public-6067e3dfbf6fca033668ddbc","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check play in Wechseljahre?","score":20.62980404,"snippet":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","sources":[],"title":"What role does Cardio Risk Check play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6067e3dfbf6fca033668ddbc/what-role-does-cardio-risk-check-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidence but are not yet universally recommended. The utility is highest when results are interpreted by a clinician and combined with lifestyle factors. Caveat: a single test does not diagnose disease, and over-testing can lead to unnecessary anxiety. Evidence level: practice (established medical practice) with moderate support from guidelines. Sources: none from provided context; general medical consensus.","area":"gesundheit","canonical_id":"gesundheit:canonical-3049975753fbff794ddd57e3","id":"public-0d36aa4284a9d0da95835378","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check useful for Wechseljahre?","score":19.76966426,"snippet":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidenc","sources":[],"title":"Is Cardio Risk Check useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0d36aa4284a9d0da95835378/is-cardio-risk-check-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}